臨床試驗(yàn)經(jīng)費(fèi)管理的水平影響臨床試驗(yàn)的質(zhì)量。分析臨床試驗(yàn)經(jīng)費(fèi)管理的現(xiàn)狀以及影響臨床試驗(yàn)經(jīng)費(fèi)管理的因素，提出針對(duì)性的改進(jìn)措施。目前，臨床試驗(yàn)經(jīng)費(fèi)收入性質(zhì)不明、管理標(biāo)準(zhǔn)不一、預(yù)算編制粗獷、勞務(wù)分配不均、審批效率低下等是影響臨床試驗(yàn)經(jīng)費(fèi)管理水平的主要因素，通過完善各項(xiàng)制度、細(xì)化經(jīng)費(fèi)編制、明確分配標(biāo)準(zhǔn)、加強(qiáng)成本核算、共建信息平臺(tái)等方法提高經(jīng)費(fèi)管理的水平，進(jìn)而提高臨床試驗(yàn)的質(zhì)量，加速藥物臨床評(píng)價(jià)。

The level of clinical trial funding management influences the quality of clinical trial. This paper analyzes the current situation of the fund management of clinical trials and the factors influencing the fund management of clinical trials, and puts forward some corresponding improvement measures. The non-transparency of clinical trial funds use, management criteria disparities, imprecise budget, unreasonable labor assignment, and ineffectiveness of approval are the main factors affecting the management level of clinical trial funds. To improve the quality of clinical trials and accelerate the clinical evaluation of drugs, we should improve the management level of funds by perfecting the system, detailing the outlay, defining the distribution standard, strengthening the cost accounting and building the information platform.

“十三五”重大新藥創(chuàng)制項(xiàng)目（2017ZX09304002）